Clinical trials
Foot Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 6 |
| Unknown status | 5 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Poznan University of Medical Sciences | 4 |
| Mayuben Private Clinic | 3 |
| MiMedx Group, Inc. | 3 |
| Helsinki University Central Hospital | 2 |
| Axolotl Biologix | 1 |
| Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 1 |
| C5 Biomedical | 1 |
| Cardiff and Vale University Health Board | 1 |
| CrannMed | 1 |
| Escola Superior de Enfermagem de Coimbra | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Foot Diseases | 43 |
| Diabetic Foot | 9 |
| Diabetes Mellitus | 8 |
| Foot Ulcer | 7 |
| Diabetes Complications | 4 |
| Diabetic Neuropathies | 4 |
| Fasciitis, Plantar | 4 |
| Musculoskeletal Diseases | 4 |
| Pain | 4 |
| Ulcer | 4 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.